Tuberculosis

CDC funding to be used for development of TB vaccine trial sites in India

Published in Vaccine Weekly, October 20th, 2004

Aeras Global TB Vaccine Foundation announced a $925,000 cooperative agreement from the U.S. Centers for Disease Control and Prevention to conduct epidemiologic studies in preparation for clinical trials of new tuberculosis (TB) vaccines in India.

The funding is renewable for up to 3 years. Aeras has received major funding from the Bill & Melinda Gates Foundation, but the cooperative agreement with CDC marks the first government contribution to Aeras.

"We look forward to working with the CDC to rapidly move promising vaccine candidates into clinical trials," said Aeras CEO Jerald Sadoff. "This critical support from the U.S. government marks...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2004-10-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry